NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Quanterix Corporation Common Stock (QTRX) Stock Analysis

Quanterix Corporation Common Stock (QTRX) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

QTRX

$2.79

+$0.07 (+2.57%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare QTRX with… →

QTRX Key Statistics

As of Oct 21, 2026
Trading
Open
$2.71
Previous Close
$2.72
Day's Range
2.68–2.82
52-Week Range
2.15–8.77
Volume
525.24K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.01
Valuation
Market Cap
$131.95M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.86
EPS (ttm)Profit attributable to each share over the last twelve months.
−2.61
Financials (FY)
Revenue (FY)
$138.65M+2.38%
Net Income (FY)
−$107.15M
Profit marginThe share of revenue left as profit after all costs and taxes.
−80.25%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
47.29M
1-Year Return
−53.96%
Dividend and dates
Earnings Date
November 9, 2026estimated
Avg Volume
747.84K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, QTRX closed at $2.79, −53.96% over 1 year.

Quanterix Corporation Common Stock (QTRX) has a market capitalization of $131.95M.

In fiscal 2025, QTRX reported revenue of $138.65M.

QTRX Stock Return by Calendar Year

Quanterix Corporation Common Stock (QTRX) return since Dec 2017: what $10,000 became

1 year
$10,000 $4,604
−53.96%
5 years
$10,000 $554
−94.46%
Since Dec 2017
$10,000 $1,597
−84.03%

If you had invested $10,000 in Quanterix Corporation Common Stock (QTRX) at the close on December 7, 2017, the earliest close on record here, it would have been worth $1,597 at the close on October 21, 2026: −84.03% in total, −18.68% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−56.13%
2025−40.17%
2024−61.12%
2023+97.40%
2022−67.33%
2021−8.82%
2020+96.78%
2019+29.06%
2018−14.72%
2017 (partial year)+22.90%

As of October 21, 2026.

QTRX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$138.65M−$107.15M−77.3%
2024$135.44M−$38.53M−28.4%
2023$121.14M−$28.35M−23.4%
2022$104.95M−$99.57M−94.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$138.65M$64.72M−$109.82M−$107.15M−77.3%
2024$135.44M$81.12M−$52.62M−$38.53M−28.4%
2023$121.14M$73.00M−$44.66M−$28.35M−23.4%
2022$104.95M$44.79M−$74.71M−$99.57M−94.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

QTRX Valuation vs Medical Devices Median

Median of 145 stocks
MetricQTRXMedical Devices medianvs median
P/S ratio0.862.5366% below
Profit margin−80.25%−14.78%65.5 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 15 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Quanterix Corporation Common Stock (QTRX) is capitalised at $131.95M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 450.

Over the past 52 weeks the price has ranged from $2.15 to $8.77. QTRX last closed at $2.79 on October 21, 2026. That is +$0.07 (+2.57%) against the previous close. The latest close sits 29.77% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $138.65M. Against the prior fiscal year total of $135.44M, that is a change of +2.38%. The same year closed with a net loss of $107.15M. Profit margin runs at −80.25%. That is 65.5 percentage points below the Medical Devices median of −14.78%. Trailing earnings per share are −2.61.

Across the 4 fiscal years on file, revenue moves from $104.95M in 2022 to $138.65M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 0.86 times revenue. On price-to-sales that is 66% below the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

The trailing one-year total return is −53.96%. Across 5 years the annualized return works out at −43.94%. The reported beta is 1.01. Daily returns over the trailing 8 years annualize to a volatility of 80.05%.

Growth & Income

The record shows no dividend for QTRX.

So far in 2026 the total return is −56.13%. Across the complete calendar years on file, 2023 returned +97.40% and 2022 returned −67.33%. Of the 8 complete calendar years on file, 3 finished higher.

Peer Comparison

Quanterix Corporation Common Stock (QTRX) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Quanterix Corporation Common Stock QTRX $131.95M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Quanterix Corporation Common Stock has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Quanterix Corporation Common Stock

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Visit website →